Bumrungrad Hospital Public Company Limited (SET: BH) has announced its 2Q22 consolidated financial statement through the Stock Exchange of Thailand as follows;
| Quarter | 2Q22 | 2Q21 |
| Net Profit (Loss) Million Baht |
1,166 | 216 |
| Earning Per Share (Baht) |
1.47 | 0.27 |
| % Change | 438.6 | |
| 6 Months | 2022 | 2021 |
| Net Profit (Loss) Million Baht |
1,891 | 308 |
| Earning Per Share (Baht) | 2.38 | 0.39 |
| % Change | 514.8 | |
BH reported total revenues in 2Q22 of THB4,954 million, a 64.0% increase from THB3,020 million in 2Q21. Net profit for 2Q22 increased by 438.6% to THB1,166 million from THB216 million in 2Q21, with Net profit margin at 23.5% in 2Q22, compared to 7.2% in 2Q21.
BH reported revenues from hospital operations of THB4,903 million, a 64.5% increase year-over-year from THB2,980 million in 2Q21. This was mostly due to an increase in revenues from non-Thai patients and Thai patients by 120.8% and 15.8%, respectively. As a result, the revenue contribution from Thai patients was 37.7%, whereas revenue from non-Thai patients was 62.3% for 2Q22 compared with 53.6% and 46.4%, respectively, for 2Q21.
Meanwhile, total revenues for 1H22 increased to THB9,106 million, or 59.9% increase from THB5,694 million in 1H21. Net profit for 1H22 increased by 514.8% to THB1,891 million from THB308 million in 1H21, with Net profit margin at 20.8% in 1H22 compared to 5.4% in 1H21.
As of 10:38 a.m. Thai time, the share price of BH rose THB12.00/share or 6.59% to THB194.00/share, with a trading value of THB1,416 million.
